Melinda Brown
About Melinda Brown
Melinda Brown, age 68, has served on the DTIL Board since May 2022 and is Chair of the Audit Committee. She is a CPA with deep leadership experience in accounting, finance, and enterprise risk management, including roles at Tapestry, Inc. (SVP & Controller, 2012–2019) and 30 years at PepsiCo culminating as SVP, Global Financial Shared Services & Productivity; she holds a BS in Accounting and an MBA from the University of Connecticut and began her career at Coopers & Lybrand and the Financial Accounting Standards Board .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Tapestry, Inc. | SVP & Controller | 2012–2019 | Led global control, supported brand acquisitions/integration and SAP implementation |
| PepsiCo, Inc. | SVP, Global Financial Shared Services & Productivity | 30 years (most recent role) | Led shared services, global finance outsourcing strategy, multi‑year productivity programs |
| Coopers & Lybrand; FASB | Early career | Not disclosed | Foundational accounting experience |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| University of Connecticut Foundation | Chair Emeritus; prior Audit Chair | Not disclosed | Served on Executive and Finance committees |
| AICPA; CT Society of CPAs | Member | Not disclosed | Professional affiliations |
Board Governance
- Independence: The Board determined Melinda Brown is independent under Nasdaq rules (one of five independent directors) .
- Committee assignments: Audit Committee Chair; not listed as a member of Compensation, Nominating & Governance, or Science & Technology committees .
- Financial expertise: The Board determined Brown qualifies as an “audit committee financial expert” (Item 407(d)(5) of Regulation S‑K) .
- Attendance and engagement: In 2024, Board met 7x; Audit 4x; Compensation 3x; Nominating 2x; Science & Tech 6x. Each incumbent director attended at least 75% of Board and applicable committee meetings; all directors attended the 2024 annual meeting .
- Audit Committee report: Brown signed the 2024 Audit Committee Report recommending inclusion of audited financials in the 10‑K .
- Board class reclassification: On March 4, 2025, Brown was reclassified from Class III to Class I (immediate reappointment). For all other purposes, including committee service and compensation, her service is deemed uninterrupted .
Committee Matrix (current as disclosed)
| Director | Audit | Compensation | Nominating & Governance | Science & Technology |
|---|---|---|---|---|
| Melinda Brown | Chair | — | — | — |
| Kevin J. Buehler | Member | — | Member | — |
| Stanley R. Frankel, M.D. | — | — | — | Chair |
| Geno Germano | Member | Chair | — | Member |
| Shari Lisa Piré | — | Member | Chair | — |
Fixed Compensation
| 2024 Director Compensation | Fees Earned ($) | Stock Awards ($) | Total ($) |
|---|---|---|---|
| Melinda Brown | 55,000 | 129,998 | 184,998 |
Non‑Employee Director Compensation Policy specifics:
- Annual director cash fees: Chair of Board $72,500; other directors $40,000; committee chairs/members fees: Audit Chair $15,000; Audit member $7,500; Compensation Chair $12,250; Compensation member $6,000; Science & Tech Chair $12,250; Science & Tech member $6,000; Nominating Chair $8,250; Nominating member $4,500. Paid quarterly in arrears, prorated for partial service .
- Equity grants: Annual RSUs determined by board‑set aggregate value/FMV at grant; initial director grants may be options or RSUs; annual director RSUs vest in a single installment on the earlier of the day before the next annual meeting or first anniversary; initial RSUs vest in 12 substantially equal quarterly installments; options vest monthly over 36 months. All unvested options/RSUs vest in full upon a change in control .
Performance Compensation
- Director equity is time‑based (RSUs/options) with no disclosed performance metrics for non‑employee directors. No director performance scorecards or TSR/EBITDA targets are disclosed for director equity grants .
| Performance Metrics for Director Pay | Disclosed? |
|---|---|
| TSR/relative TSR | Not disclosed |
| Revenue/EBITDA goals | Not disclosed |
| ESG metrics | Not disclosed |
Other Directorships & Interlocks
- Public company boards: None disclosed for Brown in the DTIL proxy’s biography section .
- Notable external board: University of Connecticut Foundation (Chair Emeritus; prior Audit Chair) .
- Interlocks/relationships: Compensation consultant Aon engaged by the Compensation Committee; a subsidiary of Aon also served as broker for D&O insurance (fees: $45,442 for comp consulting; $225,000 for D&O brokerage in 2024). The Compensation Committee evaluated independence and determined no conflict; D&O brokerage engagement was recommended by management and approved by the Board .
Expertise & Qualifications
- CPA; audit and financial literacy (audit committee financial expert) .
- Enterprise risk management leadership at large public companies (PepsiCo; Tapestry) .
- M&A integration and ERP/SAP implementation experience .
- Governance: Prior audit committee chair at UConn Foundation .
Equity Ownership
| Measure (as of March 20, 2025) | Quantity | % Outstanding |
|---|---|---|
| Beneficial ownership (total) | 19,425 shares | <1% |
| Breakdown: Common shares | 7,218 | — |
| Breakdown: Options exercisable within 60 days | 12,207 | — |
| RSUs vesting within 60 days | Not disclosed for Brown | |
| Shares outstanding basis | 10,481,931 shares | — |
Director outstanding awards at 12/31/2024:
| Instrument | Vested | Unvested |
|---|---|---|
| Stock options (#) | 10,812 | 1,744 |
| RSUs (# not vested) | 9,826 | — |
Ownership alignment policies:
- Corporate Governance Guidelines address stock ownership for directors (no numeric multiple disclosed in proxy); guidelines posted on company website .
- Anti‑hedging: Directors are prohibited from hedging DTIL securities (e.g., prepaid variable forwards, equity swaps, collars, exchange funds) .
Insider Trades and Section 16(a) Compliance
| Item | 2024 Status | Notes |
|---|---|---|
| Section 16(a) filings | All timely except delayed Form 4s for certain executives; Brown not listed among exceptions | |
| Form 4 transaction details | Not disclosed for Brown in proxy; insider‑trades data tool unavailable during this analysis | Attempted Form 4 fetch failed due to authorization error (tool) [insider-trades SKILL.md; run error]. See Section 16(a) disclosure . |
Governance Assessment
-
Strengths:
- Independent Audit Chair with audit committee financial expert designation; robust audit committee remit including related‑party transaction oversight, ICFR, cybersecurity risk, and ESG matters tied to financials .
- Attendance: Incumbent directors met ≥75% threshold; full attendance at the annual meeting, supporting engagement .
- Anti‑hedging policy and clawback policy (for executives) enhance alignment and accountability frameworks .
- Clear director compensation structure; Brown’s cash fees align with Audit Chair schedule ($40,000 director + $15,000 Audit Chair = $55,000) and annual RSU grants consistent with policy .
-
Potential conflicts/monitoring points:
- Aon dual roles (comp consultant and D&O broker). Independence evaluated and no conflict found; D&O brokerage engagement was management‑recommended and Board‑approved—appropriate disclosure but worth monitoring for ongoing independence .
- Director ownership guidelines exist but numeric thresholds not disclosed in proxy—cannot assess compliance versus guidelines from the filing alone .
-
Signals affecting investor confidence:
- Reclassification of director classes (including Brown to Class I) was administrative to equalize classes; service deemed uninterrupted—no governance dispute implied .
- Audit Committee’s 2024 report and recommendation to include audited financials in 10‑K supports effective oversight .
- Section 16(a) compliance note did not include Brown among delayed filers for 2024, supporting compliance .
Fixed Compensation Details (Policy Reference)
| Component | Amount ($) | Notes |
|---|---|---|
| Director annual fee (non‑Chair) | 40,000 | Quarterly in arrears; prorated if partial service |
| Audit Committee Chair | 15,000 | Brown is Audit Chair |
| Annual RSU grant (2024) | 9,826 RSUs | Vest in single installment (day before next annual meeting or first anniversary) |
| RSU grant fair value (2024) | 129,998 | ASC 718 grant‑date fair value |
Other Governance Disclosures
- Executive sessions: Non‑management director sessions regularly held; at least twice per year independent directors meet privately; presided by the independent Chair or Lead Director as applicable .
- Say‑on‑Pay: First advisory vote held in 2025; Board recommended FOR and annual frequency .
- Related‑party transaction policy: Audit Committee approves/ratifies transactions per Item 404; directors with interests recuse; policy summarized in proxy .
RED FLAGS
- Consultant dual engagement (Aon) could pose perceived conflict risk; mitigated by independence assessment and disclosure, but monitor future engagements and fee arrangements .
- No explicit pledging prohibition disclosed in proxy; hedging prohibited—investors may prefer explicit anti‑pledging policy clarity .
Overall, Brown’s independent status, audit leadership, financial expertise, and attendance underpin board effectiveness; disclosures on consultant independence and anti‑hedging/clawback policies support governance alignment. Continued monitoring of consultant roles and disclosure of director ownership guideline thresholds would further strengthen investor confidence. **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:29]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:30]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:32]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:31]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:37]** **[1357874_0001140361-25-013867_ny20038513x772_def14a.htm:20]**